The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems.


Updates from The Motley Fool

Latest updates on Antares Pharma from Fool.com.


Stock Performance

ATRS vs. S&P 500 | 2 Year Performance
View Interactive ATRS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Antares Pharma.
Current Price: $1.22
Prev Close: $1.26
Open: $1.27
Bid: $1.20
Ask: $1.34
Day's Range: $1.21 - $1.27
52wk Range: $0.67 - $2.03
Volume: 944,585
Avg Vol 819,691
Market Cap: $188.89M
P/E (ttm): -7.41
EPS (ttm): -$0.17
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Antares Pharma.
CAPS Rating 3 out of 5
 
182 Outperform
14 Underperform
CAPS All Stars
 
11 Outperform
3 Underperform

How do you think Antares Pharma will perform against the market?



You pick for Antares Pharma is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Paul K. Wotton, CEO

48% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Antares Pharma.

The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral fast melting tablets and reusable needle-free and disposable mini-needle injector systems.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT